Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Caitlin T. Fierheller
Observed names:
C Fierheller,
C. Fierheller,
Caitlin Fierheller,
Caitlin T Fierheller,
Fierheller, Caitlin,
Fierheller, Caitlin T.
show all 6
Institutions:
Queen Mary University of London,
McGill University Health Centre,
Research Institute of the McGill University Health Centre,
McGill University
Observed institutions:
Queen Mary University of London,
Barts Health NHS Trust,
Royal London Hospital,
Cancer Research UK,
McGill University Health Centre,
Research Institute of the McGill University Health Centre,
McGill University
show all 7
ORCID:
0000-0001-9583-3061
Observed ORCID:
0000-0001-9583-3061
OpenAlex ID:
A5009194879
Literature Review of BARD1 as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers
2020
·
Wejdan M. Alenezi
, Caitlin T. Fierheller
, et al.
·
Genes
·
59
PDF
Cost-Effectiveness of Gene-Specific Prevention Strategies for Ovarian and Breast Cancer
2024
·
Xia Wei
, Li Sun
, et al.
·
JAMA Network Open
·
30
PDF
A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing gene
2021
·
Caitlin T. Fierheller
, Laure Guitton-Sert
, et al.
·
Genome Medicine
·
25
PDF
Uptake and patient-related outcomes of mainstreaming genetic testing: a systematic review and meta-analysis
2025
·
Ashwin Kalra
, Subhasheenee Ganesan
, et al.
·
American Journal of Obstetrics and Gynecology
·
21
Economic Evaluation of Population-Based BRCA1 and BRCA2 Testing in Canada
2024
·
Li Sun
, Xia Wei
, et al.
·
JAMA Network Open
·
20
The Genetic Analyses of French Canadians of Quebec Facilitate the Characterization of New Cancer Predisposing Genes Implicated in Hereditary Breast and/or Ovarian Cancer Syndrome Families
2021
·
Caitlin T. Fierheller
, Wejdan M. Alenezi
, et al.
·
Cancers
·
20
PDF
The Genetic and Molecular Analyses of RAD51C and RAD51D Identifies Rare Variants Implicated in Hereditary Ovarian Cancer from a Genetically Unique Population
2022
·
Wejdan M. Alenezi
, Larissa Milano
, et al.
·
Cancers
·
16
PDF
Defining Lifetime Risk Thresholds for Breast Cancer Surgical Prevention
2025
·
Xia Wei
, Lea Mansour
, et al.
·
JAMA Oncology
·
14
PDF
Cost-Effectiveness of Unselected Multigene Germline and Somatic Genetic Testing for Epithelial Ovarian Cancer
2024
·
Ranjit Manchanda
, Li Sun
, et al.
·
Journal of the National Comprehensive Cancer Network
·
13
PDF
Genetic analyses of DNA repair pathway associated genes implicate new candidate cancer predisposing genes in ancestrally defined ovarian cancer cases
2023
·
Wejdan M. Alenezi
, Caitlin T. Fierheller
, et al.
·
Frontiers in Oncology
·
13
Molecular Genetic Characteristics of FANCI, a Proposed New Ovarian Cancer Predisposing Gene
2023
·
Caitlin T. Fierheller
, Wejdan M. Alenezi
, et al.
·
Genes
·
11
PDF
Case Review: Whole-Exome Sequencing Analyses Identify Carriers of a Known Likely Pathogenic Intronic BRCA1 Variant in Ovarian Cancer Cases Clinically Negative for Pathogenic BRCA1 and BRCA2 Variants
2022
·
Wejdan M. Alenezi
, Caitlin T. Fierheller
, et al.
·
Genes
·
9
PDF
Estimands for Clinical Effectiveness of Risk-Reducing Early Salpingectomy in Women With High Risk of Ovarian Cancer
2025
·
Jacqueline Sia
, Emily F. Lane
, et al.
·
JAMA Network Open
·
6
PDF
The Genetic and Molecular Analyses of Rare Candidate Germline BRIP1/FANCJ Variants Implicated in Hereditary Breast and Ovarian Cancers
2026
·
Larissa Milano
, Wejdan M. Alenezi
, et al.
·
International Journal of Molecular Sciences
·
3
PDF
Patient decision aids in mainstreaming genetic testing for women with ovarian cancer: A prospective cohort study
2023
·
Monika Sobocan
, Dhivya Chandrasekaran
, et al.
·
BJOG An International Journal of Obstetrics & Gynaecology
·
3
Risk of ovarian cancer in women with a pathogenic or likely pathogenic variant in NBN: a systematic review and meta-analysis
2026
·
Subhasheenee Ganesan
, Lea Mansour
, et al.
·
American Journal of Obstetrics and Gynecology
·
2
P-POSSUM Falls Short: Predicting Morbidity in Ovarian Cancer (OC) Cytoreductive Surgery
2025
·
Michail Sideris
, Mark R. Brincat
, et al.
·
Cancers
·
2
PDF
Health-Related Quality Of Life After Risk-Reducing Hysterectomy: A Cross-Sectional Study Of Women With Lynch Syndrome
2025
·
Samuel Oxley
, Milly Lake
, et al.
·
International Journal of Gynecological Cancer
·
2
PDF
Utility Scores for Risk-Reducing Mastectomy and Risk-Reducing Salpingo-Oophorectomy: Mapping to EQ-5D
2024
·
Samuel G. Oxley
, Xia Wei
, et al.
·
Cancers
·
2
PDF
Routine germline genetic testing in 3552 unselected NHS breast cancer patients: evidence informing testing criteria and implementation of a ‘BRCA-DIRECT’ mainstreaming pathway
2026
·
Bethany Torr
, Lea Mansour
, et al.
·
npj Breast Cancer
·
1
PDF
Risk of ovarian cancer in women with a pathogenic or likely pathogenic variant in NBN in 38,337 women: a systematic review and meta-analysis
2026
·
Subhasheenee Ganesan
, Lea Mansour
, et al.
·
International Journal of Gynecological Cancer
·
1
Consent model for tumour genetic testing in ovarian cancer
2025
·
Caitlin T. Fierheller
, Elaine Y. L. Leung
, et al.
·
Journal of Obstetrics and Gynaecology
·
1
PDF
Uptake And Patient-Related Outcomes Of Mainstreaming Genetic Testing – A Systematic Review And Meta-Analysis
2025
·
Ashwin Kalra
, Subhasheenee Ganesan
, et al.
·
International Journal of Gynecological Cancer
·
1
Online Provision of BRCA1 and BRCA2 Health Information: A Search Engine Driven Systematic Web-Based Analysis
2024
·
Tamar A. Gootzen
, Ashwin Kalra
, et al.
·
Cancers
·
1
PDF
BRCA awareness and testing experience in the UK Jewish population: a qualitative study
2024
·
Katrina Sarig
, Samuel Oxley
, et al.
·
Journal of Medical Genetics
·
1
Show more works
View as search
Works count:
59
Citation count:
281
H-index:
11
I10-index:
11
Year
Topic
Type